Atherosclerosis-related circulating miRNAs as novel and sensitive predictors for acute myocardial infarction

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Wang, Feng ^a   Long, Guangwen ^a   Zhao, Chunxia ^a   Li, Huaping ^a   Chaugai, Sandip ^a   Wang, Yan ^a   Chen, Chen ^a   Wang, Dao Wen ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 21 5P; MICRORNA 361 5P; MICRORNA 519E 5P; TROPONIN I; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIRN21 MICRORNA, HUMAN; MIRN361 MICRORNA, HUMAN; MIRN519 MICRORNA, HUMAN;

ACUTE HEART INFARCTION; ADULT; AREA UNDER THE CURVE; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BRAIN INFARCTION; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; AGED; BLOOD; CASE CONTROL STUDY; CELL HYPOXIA; GENETICS; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOLOGY; PULMONARY EMBOLISM; RECEIVER OPERATING CHARACTERISTIC; STROKE;

ADULT; AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CELL HYPOXIA; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PULMONARY EMBOLISM; ROC CURVE; STROKE; TROPONIN I;

EID: 84906976964     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105734     Document Type: Article

References (45)

1. White HD, Chew DP (2008) Acute myocardial infarction. Lancet 372:570-584.
2. de Winter RJ, Koster RW, Sturk A, Sanders GT (1995) Value of myoglobin, troponin T, and CK-MBmass in ruling out an acute myocardial infarction in the emergency room. Circulation 92:3401-3407.
3. Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, et al. (2000) It's time for a change to a troponin standard. Circulation 102:1216-1220.
4. Finsterer J, Stollberger C, Krugluger W (2007) Cardiac and noncardiac, particularly neuromuscular, disease with troponin-T positivity. Neth J Med 65:289-295.
5. Abbas NA, John RI, Webb MC, Kempson ME, Potter AN, et al. (2005) Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin Chem 51:2059-2066.
6. Rosjo H, Varpula M, Hagve TA, Karlsson S, Ruokonen E, et al. (2011) Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med 37:77-85.
7. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
8. Ambros V (2004) The functions of animal microRNAs. Nature 431:350-355.
9. Plasterk RH (2006) Micro RNAs in animal development. Cell 124:877-881.
10. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105:10513-10518.
11. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, et al. (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3:e3148.
12. Kroh EM, Parkin RK, Mitchell PS, Tewari M (2010) Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50:298-301.
13. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, et al. (2008) Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141:672-675.
14. Schwabbauer ML (1975) Use of the latent image technique to develop and evaluate problem-solving skills. Am J Med Technol 41:457-462.
15. Mouillet JF, Chu T, Hubel CA, Nelson DM, Parks WT, et al. (2010) The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction. Placenta 31:781-784.
16. Jickling GC, Sharp FR (2011) Blood biomarkers of ischemic stroke. Neurotherapeutics 8:349-360.
17. Li S, Zhu J, Zhang W, Chen Y, Zhang K, et al. (2011) Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation 124:175-184.
18. Shi W, Du J, Qi Y, Liang G, Wang T, et al. (2012) Aberrant expression of serum miRNAs in schizophrenia. J Psychiatr Res 46:198-204.
19. Cui L, Qi Y, Li H, Ge Y, Zhao K, et al. (2011) Serum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease. PLoS One 6:e27071.
20. Oerlemans MI, Mosterd A, Dekker MS, de Vrey EA, van Mil A, et al. (2012) Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs. EMBO Mol Med 4:1176-1185.
21. Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, et al. (2010) MiR423-5p as a circulating biomarker for heart failure. Circ Res 106:1035-1039.
22. Adachi T, Nakanishi M, Otsuka Y, Nishimura K, Hirokawa G, et al. (2010) Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem 56:1183-1185.
23. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, et al. (2010) Circulating microRNAs in patients with coronary artery disease. Circ Res 107:677-684.
24. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, et al. (2010) Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 31:2765-2773.
25. Zampetaki A, Willeit P, Tilling L, Drozdov I, Prokopi M, et al. (2012) Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol 60:290-299.
26. Gupta SK, Bang C, Thum T (2010) Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Circ Cardiovasc Genet 3:484-488.
27. Rhodes CJ, Wharton J, Boon RA, Roexe T, Tsang H, et al. (2013) Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension. Am J Respir Crit Care Med 187:294-302.
28. Creemers EE, Tijsen AJ, Pinto YM (2012) Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 110:483-495.
29. Finn NA, Eapen D, Manocha P, Al Kassem H, Lassegue B, et al. (2013) Coronary heart disease alters intercellular communication by modifying microparticle-mediated microRNA transport. FEBS Lett.
30. Zhang Y, Liu D, Chen X, Li J, Li L, et al. (2010) Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 39:133-144.
31. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT (2011) MicroRNAs are transported in plasma and delivered to recipient cells by highdensity lipoproteins. Nat Cell Biol 13:423-433.
32. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, et al. (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31:659-666.
33. Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, et al. (2011) Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet 4:446-454.
34. Wang F, Long G, Zhao C, Li H, Chaugai S, et al. (2013) Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis. J Transl Med 11:222.
35. Long G, Wang F, Duan Q, Chen F, Yang S, et al. (2012) Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. Int J Biol Sci 8:811-818.
36. Kumarswamy R, Volkmann I, Thum T (2011) Regulation and function of miRNA-21 in health and disease. RNA Biol 8:706-713.
37. Cheng Y, Zhang C (2010) MicroRNA-21 in cardiovascular disease. J Cardiovasc Transl Res 3:251-255.
38. van Rooij E, Sutherland LB, Thatcher JE, Di Maio JM, Naseem RH, et al. (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 105:13027-13032.
39. Dong S, Cheng Y, Yang J, Li J, Liu X, et al. (2009) MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem 284:29514-29525.
40. Liu D, Tao T, Xu B, Chen S, Liu C, et al. (2014) MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6 (STAT6). Biochem Biophys Res Commun 445:151-156.
41. Kanitz A, Imig J, Dziunycz PJ, Primorac A, Galgano A, et al. (2012) The expression levels of microRNA-361-5p and its target VEGFA are inversely correlated in human cutaneous squamous cell carcinoma. PLoS One 7:e49568.
42. Kotlabova K, Doucha J, Hromadnikova I (2011) Placental-specific microRNA in maternal circulation-identification of appropriate pregnancy-associated microRNAs with diagnostic potential. J Reprod Immunol 89:185-191.
43. Boeckel JN, Thome CE, Leistner D, Zeiher AM, Fichtlscherer S, et al. (2013) Heparin selectively affects the quantification of microRNAs in human blood samples. Clin Chem 59:1125-1127.
44. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, et al. (2012) Third universal definition of myocardial infarction. Circulation 126:2020-2035.
45. Brase JC, Johannes M, Schlomm T, Falth M, Haese A, et al. (2011) Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer 128:608-616.